Economist Podcasts The Economist
-
- Nachrichten
-
Every weekday our global network of correspondents makes sense of the stories beneath the headlines. We bring you surprising trends and tales from around the world, current affairs, business and finance — as well as science and technology.
Hosted on Acast. See acast.com/privacy for more information.
-
The Intelligence: AI rest my case
The companies behind this wonder of tech are facing allegations of using copyrighted material to build their large language models (LLMs). But will the courts consider it fair use? Why ex-inmates are so likely to die just after they leave prison (10:15). And, the case for booing in sports (16:13).
Listen to what matters most, from global politics and business to science and technology—Subscribe to Economist Podcasts+
For more information about how to access Economist Podcasts+, please visit our FAQs page or watch our video explaining how to link your account.
Hosted on Acast. See acast.com/privacy for more information. -
The Intelligence: Ready, Aid, Fire
At a time when Russia has been making significant gains, an allocated $61bn of aid for Ukraine will be felt on the battlefield almost instantly. Will it help turn the course of the war? In a world of endless supply chain disruptions, how can businesses shore up against the costs (11:26)? And the appeal of two-month-old stew (18:37).
Listen to what matters most, from global politics and business to science and technology—Subscribe to Economist Podcasts+
For more information about how to access Economist Podcasts+, please visit our FAQs page or watch our video explaining how to link your account.
Hosted on Acast. See acast.com/privacy for more information. -
The Weekend Intelligence: Kennedy for president?
Robert F. Kennedy junior is channelling his most famous uncle in his bid to become America’s next president. Mr Kennedy is an outsider, a political dynast, a government and vaccine sceptic, a lifelong falconer and more. But is he a potential president? The Economist's Andrew Miller sat down with the man with the famous name to find out.
-
The Intelligence: Iran and Israel’s new era?
A missile has reportedly struck a site in the Islamic Republic. If this is retaliation for Iran’s most recent attacks, then it is a muted response. But is there still a risk of escalation? As India’s election kicks off, a look into why the opposition is likely to have a poor showing (09:07). And, a tribute to the first foreign-born grand champion of sumo (19:15).
Listen to what matters most, from global politics and business to science and technology—Subscribe to Economist Podcasts+
For more information about how to access Economist Podcasts+, please visit our FAQs page or watch our video explaining how to link your account.
Hosted on Acast. See acast.com/privacy for more information. -
Checks and Balance: Stormy weather
A jury has been selected in Donald Trump's criminal trial in Manhattan. The case has been criticised as flawed and partisan, but of the four indictments against Mr Trump, it may be the only one to produce a verdict before the election. Now the trial is underway, what should one make of it? And what difference could a guilty verdict make?
John Prideaux hosts with Charlotte Howard and Idrees Kahloon. Jed Shugerman of Boston University and The Economist’s James Bennet and Kennett Werner also contribute.
Listen to what matters most, from global politics and business to science and technology—Subscribe to Economist Podcasts+
For more information about how to access Economist Podcasts+, please visit our FAQs page or watch our video explaining how to link your account. -
Money Talks: Why weight-loss drugs will reshape the world
More than 1bn people around the world are obese. That means there should be extraordinary demand for drugs to cure or mitigate the condition. Novo Nordisk is now Europe’s most valuable company and Eli Lilly’s market value has more than doubled. Both make the “miracle” drugs that can help people shed up to a fifth of their body weight. But these drugs promise to do more than boost drug companies’ profits. How will they reshape the economy?
Hosts: Alice Fulwood, Mike Bird and Tom Lee-Devlin. Guests: The Economist’s Georgia Banjo; pharmaceuticals analyst Michael Nedelcovych; and John Cawley, a professor of public policy and economics at Cornell University.
Subscribers to Economist Podcasts+ can listen to our January 2023 episode on the economics of thinness.
Sign up for our new weekly newsletter dissecting the big themes in markets, business and the economy at www.economist.com/moneytalks
Listen to what matters most, from global politics and business to science and technology—subscribe to Economist Podcasts+
For more information about how to access Economist Podcasts+, please visit our FAQs page or watch our video explaining how to link your account.
Hosted on Acast. See acast.com/privacy for more information.
Kundenrezensionen
Weekend Intelligence
Life and fate a tremendous tribute to Alexander Navalny and others who do what is right.
Thank you
Extremely well-researched, insightful podcasts
I literally could listen to any of the podcasts, and will never be disappointed. The podcasts are discussing the most pressing items that shape our world, are extremely well researched and discuss the items in detail. Unfortunately, I dont have enough time to listen to it all. What a pity …
European Right
Anyone Centre or Right is now thanks to The Economist ,carries the prefix Far or Hard.As a subscriber for more than 20 years I have seen this once balanced weekly become a Woke publication.Out-of touch with the reality of most Europeans.The root is the usual suspects……….